Target type: biologicalprocess
The chemical reactions and pathways resulting in the breakdown of sphingomyelin, N-acyl-4-sphingenyl-1-O-phosphorylcholine. [ISBN:0198506732]
The sphingomyelin catabolic process is a crucial biochemical pathway involved in the breakdown of sphingomyelin, a major phospholipid component of cell membranes. This process plays a significant role in various cellular functions, including membrane remodeling, signal transduction, and apoptosis.
The breakdown of sphingomyelin begins with the action of **sphingomyelinases**, a family of enzymes that hydrolyze the phosphodiester bond between the phosphocholine head group and ceramide. There are two main types of sphingomyelinases: **acid sphingomyelinase (ASM)** and **neutral sphingomyelinase (NSM)**.
**ASM** is an lysosomal enzyme that optimally functions at acidic pH. It is responsible for the catabolism of sphingomyelin within lysosomes. Deficiency of ASM leads to Niemann-Pick disease, a severe genetic disorder characterized by accumulation of sphingomyelin in various tissues.
**NSM** is a plasma membrane-associated enzyme that functions at neutral pH. It is involved in the breakdown of sphingomyelin at the cell surface and plays a role in signal transduction pathways.
The hydrolysis of sphingomyelin by sphingomyelinases generates **ceramide**, a bioactive lipid that acts as a second messenger in various cellular processes. Ceramide can be further metabolized into other sphingolipids, such as **sphingosine**, **sphingosine-1-phosphate (S1P)**, and **ceramide-1-phosphate (C1P)**.
These sphingolipids have distinct biological activities and contribute to various cellular functions, including:
- **Membrane remodeling:** Sphingolipids are essential for the structural integrity and fluidity of cell membranes. Their turnover through catabolism is crucial for membrane remodeling and adaptation.
- **Signal transduction:** Ceramide and its metabolites act as intracellular messengers, regulating various signaling pathways involved in cell growth, differentiation, apoptosis, and inflammation.
- **Apoptosis:** Ceramide plays a central role in apoptosis, a programmed cell death process. Increased ceramide levels activate downstream signaling cascades leading to cell death.
- **Other cellular functions:** Sphingolipids are also involved in other cellular processes, such as cholesterol metabolism, immune response, and neurotransmission.
The sphingomyelin catabolic process is tightly regulated and dysregulation of this pathway can contribute to the development of various diseases, including cancer, neurodegenerative disorders, and metabolic disorders. Understanding the complex interplay of sphingolipids and their metabolic pathways is crucial for developing new therapeutic strategies targeting these diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Sphingomyelin phosphodiesterase | [no definition available] | Bos taurus (cattle) |
Sphingomyelin phosphodiesterase 3 | A sphingomyelin phosphodiesterase 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NY59] | Homo sapiens (human) |
Sphingomyelin phosphodiesterase | A sphingomyelin phosphodiesterase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17405] | Homo sapiens (human) |
Sphingomyelin phosphodiesterase 2 | A sphingomyelin phosphodiesterase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60906] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
chlorpromazine | chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety. Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. | organochlorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug |
fendiline | Fendiline: Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents. | diarylmethane | |
imipramine | imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom. Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. | dibenzoazepine | adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
inositol 2,4,6-triphosphate | |||
cambinol | cambinol: inhibitor of human silent information regulator 2 enzymes; structure in first source | ||
2-(1-benzo[e]benzofuranyl)-N-[4-methoxy-3-(4-morpholinylsulfonyl)phenyl]acetamide | naphthofuran | ||
mangostin | alpha-mangostin : A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3 and 6, a methoxy group at position 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antioxidant, antimicrobial and antitumour activities. mangostin: xanthone from rind of Garcinia mangostana Linn. fruit | aromatic ether; phenols; xanthones | antimicrobial agent; antineoplastic agent; antioxidant; plant metabolite |
scyphostatin | scyphostatin: a neutral sphingomyelinase inhibitor isolated from Trichopeziza mollissima; structure in first source | cyclohexenones |